Our experimental data indicated that CEACAM1-L expression in the context of murine MC38 CRC metastatic cells affects EPHA2 expression and signaling resulting in significantly decreased development of liver metastases in immunocompetent mice. This evidence concerns the gene EPHA2 and colorectal carcinoma.